• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结直肠癌群体筛查,突尼斯 2019 年。突尼斯地区试点项目评估(突尼斯,2019 年)。

Colorectal cancer mass screening, Tunisia 2019. Evaluation of a pilot program in the Tunis region (Tunisia, 2019).

出版信息

Tunis Med. 2021 Jan;99(1):158-167.

PMID:33899183
Abstract

INTRODUCTION

Colorectal cancer (CRC) is a real public health issue in Tunisia. A screening program based on fecal immunological occult blood test, followed in case of a positive test by colonoscopy, was launched in Tunis region in 2016. We aimed to evaluate this screening program in order to make recommendations for a better implementation of this program in years to come.

METHODS

A mixed approach has been adopted with a quantitative component based on the production of indicators related to activity, monitoring and screening quality; and a qualitative component conducted through focus groups with frontline health care professionals (HCP) and individual interviews with those lost to follow-up after a positive screening test. SWOT analysis was then performed in order to assess main strengths, weaknesses, opportunities and threats of the program.

RESULTS

This study showed a coverage rate of 41.2% [40.5-41.8] for population consulting the first line of care, and an effective participation rate estimated at 23.1% [22.6-23.6]. Out of 5856 tests performed, 6% (n=352) were non-treatable and 6.7 % (n=390) were positive. Only 18.6% (n=72) of those tested positive had undergone colonoscopy. A total of 26 polyps, 03 cases of cancer and 04 cases of dysplasia were recorded. SWOT analysis pointed out that the variable adherence of HCP, lack of awareness of general population regarding CRC screening, the non-acceptability of colonoscopy without sedation with a problem of affordability for its realization in the private sector, and long appointments delays in public sector, were main weaknesses and of this program.

CONCLUSION

This evaluation underlined certain strengths regarding the program implementation and revealed, in return, several shortcomings which certainly impair the program's effectiveness and efficiency. The involvement of the national health insurance fund in CRC screening tests and colonoscopies reimbursement, as well as the establishment of a performance-based payment modality for HCP, constitute main key pillars to reach success and sustainability for any CCR mass screening program in Tunisia.

摘要

简介

结直肠癌(CRC)在突尼斯是一个严重的公共卫生问题。2016 年,突尼斯地区启动了一项基于粪便免疫化学潜血试验的筛查计划,如果试验结果为阳性,则进一步进行结肠镜检查。我们旨在评估该筛查计划,以便为未来更好地实施该计划提出建议。

方法

采用混合方法,定量部分基于与活动、监测和筛查质量相关的指标的产生;定性部分通过与一线卫生保健专业人员(HCP)进行焦点小组讨论和对阳性筛查试验后失访者进行个别访谈进行。然后进行 SWOT 分析,以评估该计划的主要优势、劣势、机会和威胁。

结果

本研究显示,咨询第一线保健服务的人群覆盖率为 41.2%[40.5-41.8],有效参与率估计为 23.1%[22.6-23.6]。在进行的 5856 次检测中,有 6%(n=352)为不可治疗性病变,6.7%(n=390)为阳性。在检测结果为阳性的人群中,仅有 18.6%(n=72)接受了结肠镜检查。共发现 26 个息肉、03 例癌症和 04 例发育不良。SWOT 分析指出,HCP 的可变性、普通人群对 CRC 筛查的认识不足、在私营部门实现结肠镜检查时缺乏镇静剂的可接受性以及公共部门预约时间过长,这些是该计划的主要劣势。

结论

该评估强调了该计划实施的某些优势,并相应地揭示了一些缺陷,这些缺陷肯定会影响该计划的有效性和效率。将国家健康保险基金纳入 CRC 筛查试验和结肠镜检查报销范围,以及为 HCP 建立基于绩效的支付模式,是在突尼斯实现任何 CRC 大规模筛查计划取得成功和可持续性的主要关键支柱。

相似文献

1
Colorectal cancer mass screening, Tunisia 2019. Evaluation of a pilot program in the Tunis region (Tunisia, 2019).结直肠癌群体筛查,突尼斯 2019 年。突尼斯地区试点项目评估(突尼斯,2019 年)。
Tunis Med. 2021 Jan;99(1):158-167.
2
Results of National Colorectal Cancer Screening Program in Croatia (2007-2011).克罗地亚国家结直肠癌筛查计划的结果(2007-2011 年)。
World J Gastroenterol. 2012 Aug 28;18(32):4300-7. doi: 10.3748/wjg.v18.i32.4300.
3
Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.用于结直肠癌筛查的粪便潜血试验:一项基于证据的分析。
Ont Health Technol Assess Ser. 2009;9(10):1-40. Epub 2009 Sep 1.
4
Short Term Outcomes of Using Fecal Immunochemical Test for a Pilot Colorectal Cancer Screening Program. A Single Center Study on 3024 Consecutive Patients.粪便免疫化学检测用于试点结直肠癌筛查项目的短期结果。对3024例连续患者的单中心研究
Chirurgia (Bucur). 2020 Jul-Aug;115(4):448-457. doi: 10.21614/chirurgia.115.4.448.
5
Colorectal cancer screening: 20 years of development and recent progress.结直肠癌筛查:20年的发展与近期进展
World J Gastroenterol. 2014 Apr 14;20(14):3825-34. doi: 10.3748/wjg.v20.i14.3825.
6
Korean colonoscopy screening pilot study (K-cospi) for screening colorectal cancer: study protocol for the multicenter, community-based clinical trial.韩国结肠镜筛查先导研究(K-cospi)用于筛查结直肠癌:多中心、社区为基础的临床试验研究方案。
BMC Gastroenterol. 2021 Jan 26;21(1):36. doi: 10.1186/s12876-021-01610-1.
7
Health benefits and cost-effectiveness of a hybrid screening strategy for colorectal cancer.结直肠癌混合筛查策略的健康获益和成本效益。
Clin Gastroenterol Hepatol. 2013 Sep;11(9):1158-66. doi: 10.1016/j.cgh.2013.03.013. Epub 2013 Mar 28.
8
Barriers to completing colonoscopy after a positive fecal occult blood test.阳性粪便潜血试验后完成结肠镜检查的障碍。
Isr J Health Policy Res. 2021 Feb 11;10(1):11. doi: 10.1186/s13584-021-00444-2.
9
[Efficacy of the population-based pilot colorectal screening program. Hungary, Csongrád county, 2015].[基于人群的结直肠癌筛查试点项目的效果。匈牙利,琼格拉德州,2015年]
Orv Hetil. 2017 Oct;158(42):1658-1667. doi: 10.1556/650.2017.30822.
10
Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing.多次粪便免疫化学检测受试者的间期结直肠癌发病率。
Gastroenterology. 2017 Aug;153(2):439-447.e2. doi: 10.1053/j.gastro.2017.05.004. Epub 2017 May 5.

引用本文的文献

1
Neural Network-Based Composite Risk Scoring for Stratification of Fecal Immunochemical Test-Positive Patients in Colorectal Cancer Screening: Findings from South-West Oltenia.基于神经网络的粪便免疫化学检测阳性患者在结直肠癌筛查中的复合风险分层评分:来自西南奥尔泰尼亚的研究结果
Cancers (Basel). 2025 Jun 2;17(11):1868. doi: 10.3390/cancers17111868.
2
Barriers to colorectal cancer screening in the Eastern Mediterranean Region: a scoping review using the theoretical domains framework.东地中海区域结直肠癌筛查的障碍:使用理论领域框架的范围综述
J Gastrointest Oncol. 2023 Jun 30;14(3):1576-1592. doi: 10.21037/jgo-22-510. Epub 2023 Jun 27.
3
Barriers and recommendations for colorectal cancer screening in Africa.
非洲结直肠癌筛查的障碍和建议。
Glob Health Action. 2023 Dec 31;16(1):2181920. doi: 10.1080/16549716.2023.2181920.
4
40 years of Primary Health Care in Tunisia. Findings and Perspectives.突尼斯的40年初级卫生保健。调查结果与展望。
Tunis Med. 2021 Jan;99(1):1-4.